BTIG analyst Marie Thibault maintained a Buy rating on Abbott Labs (ABT – Research Report) on June 24 and set a price target of $130.00. The company's shares closed last Friday at $109.45. According to TipRanks.com, Thibault is a 4-star analyst with an average return of 6.2% and a 27.2% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Edwards Lifesciences, and Irhythm Technologies. Currently, the analyst consensus on Abbott Labs is a Strong Buy with an average price target of $138.89. See the top stocks recommended by analysts >> The company has a one-year high of $142.60 and a one-year low of $101.24.
https://www.tipranks.com/news/blurbs/btig-sticks-to-its-buy-rating-for-abbott-labs-abt?utm_source=advfn.com&utm_medium=referral
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
Von Jul 2022 bis Aug 2022 Click Here for more Abbott Laboratories Charts.
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
Von Aug 2021 bis Aug 2022 Click Here for more Abbott Laboratories Charts.